Vestor Capital, LLC Gilead Sciences, Inc. Transaction History

Vestor Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $96,300 - $109,878	-1,605 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $5,665 - $6,455	100 Added 6.64%	1,605 $94,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $16,146 - $20,300	-260 Reduced 14.73%	1,505 $95,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $16,283 - $20,857	260 Added 17.28%	1,765 $132,000
Q3 2019 Nov 20, 2019	SELL	$62.51 - $69.0 $18,440 - $20,355	-295 Reduced 16.39%	1,505 $95,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $3,093 - $3,469	50 Added 2.86%	1,800 $122,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $109,427 - $122,587	1,750 New	1,750 $114,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vestor Capital, LLC with notifications on news.